| BAL | Broncho-alveolar lavage |
| BOOP | bronchiolitis obliterans organizing pneumonia |
| CT | computed tomography |
| DAD | diffuse alveolar damage |
| DIILD | drug induced interstitial lung disease |
| DTPA | diethylene-triamine-pentaacetate |
| HMPAO | hexamethylene-propylene amine oxime |
| IBs | imaging biomarkers |
| IMI | Innovative Medicines Initiative |
| IPF | idiopathic pulmonary fibrosis |
| i.t. | intratracheal |
| i.v. | intravenous |
| i.l. | intralobular |
| i.n. | intranasal |
| i.p. | intraperitoneal |
| LPS | lipopolysaccharide |
| MRI | magnetic resonance imaging |
| NSIP | nonspecific interstitial pneumonia |
| TRISTAN | Translational Imaging in Drug Safety Assessment |
| PET | positron emission tomography |
| PRISMA | Preferred Reporting Items for Systematic reviews and Meta-analyses |
| SPECT | Single-photon emission computed tomography |
| s.c. | subcutaneous |
| TNF-α | Tumor necrosis factor-alpha |
| t.t. | transtracheal |
| UIP | usual interstitial pneumonia-like pattern |